ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1,4,Auricular swelling,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
1,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,7,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1,10,Headache,Headaches NEC,Headaches,Nerv,N
1,11,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1,12,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,14,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
1,16,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,18,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,19,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,20,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
2,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
4,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5,3,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6,3,Headache,Headaches NEC,Headaches,Nerv,N
6,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
6,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
7,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
7,4,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
7,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
7,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
7,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7,10,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
8,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
8,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
9,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
9,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
10,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
10,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
11,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
11,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
12,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
12,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
12,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
12,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
15,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
16,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
16,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
16,5,Full blood count increased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
16,6,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,7,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
17,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
18,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
18,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
18,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
20,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
20,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
21,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
23,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
23,2,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
23,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
23,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
24,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
25,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
25,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
25,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
25,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
25,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
25,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
27,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,3,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
27,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
28,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
29,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
30,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
30,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
31,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
31,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
31,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
32,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
32,3,Leukaemoid reaction,Leukocytoses NEC,White blood cell disorders,Blood,N
32,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
33,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
33,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
33,3,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
33,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
33,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
33,6,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
34,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
34,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
35,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
36,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
36,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
36,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
37,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
38,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,2,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
39,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
40,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
40,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
40,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,4,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
40,5,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
41,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
43,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
43,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
44,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
45,1,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
46,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
47,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
47,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
47,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
47,4,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
47,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
47,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
47,7,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
48,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
48,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
48,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
49,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
50,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
50,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
50,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
51,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
51,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
52,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
52,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
53,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
53,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
54,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
54,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
55,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
56,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,4,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
56,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
57,1,Anosognosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
57,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
57,3,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
57,4,Coma,Coma states,Neurological disorders NEC,Nerv,N
57,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
57,6,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
57,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
57,8,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
57,9,Headache,Headaches NEC,Headaches,Nerv,N
57,10,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
57,11,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
57,12,Hypocoagulable state,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
57,13,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,14,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
57,15,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
57,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
57,17,Transverse sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
57,18,Vasogenic cerebral oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
57,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
58,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
59,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
60,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
60,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
61,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
62,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
62,2,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
62,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
63,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
63,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
64,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
65,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
65,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
65,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
66,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
66,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
67,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
67,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
67,3,Fractured sacrum,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
67,4,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
67,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
67,6,Skeletal injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
68,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
69,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
69,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
70,1,Erythropoiesis abnormal,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
71,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
72,2,Hypertrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
72,3,Liver iron concentration increased,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
72,4,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,5,Paroxysmal nocturnal haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
72,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
72,7,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
72,9,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
73,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
74,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
74,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
74,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
74,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
74,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
75,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
76,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
76,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
76,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
76,4,Thrombocytopenia neonatal,Thrombocytopenias,Platelet disorders,Blood,N
77,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
77,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
77,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
77,5,Mucosal haemorrhage,Mucosal findings abnormal,General system disorders NEC,Genrl,N
78,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
78,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
78,3,Headache,Headaches NEC,Headaches,Nerv,N
78,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
78,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
79,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
80,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
80,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
80,3,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
80,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
80,5,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
81,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
81,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
83,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
84,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
85,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
86,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
87,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
88,1,Myelodysplastic syndrome transformation,Myelodysplastic syndromes,Leukaemias,Neopl,N
89,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
90,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
91,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
92,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
92,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
94,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
94,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
95,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
95,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
95,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
95,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
95,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,7,Headache,Headaches NEC,Headaches,Nerv,N
95,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,9,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
95,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
96,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
96,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
96,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
96,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
96,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
96,6,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
96,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
96,8,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
97,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
98,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
98,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
99,1,Headache,Headaches NEC,Headaches,Nerv,N
99,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
99,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
99,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
101,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Arteriovenous malformation,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
102,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
102,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
103,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
103,2,Aortic embolus,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
103,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,5,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
103,6,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
103,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
103,8,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
104,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
104,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
104,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
104,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
105,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
105,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
105,3,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
105,4,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
105,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
105,6,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
106,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
107,1,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
108,1,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
109,1,Cataract congenital,Lens disorders congenital,Eye disorders congenital,Cong,N
110,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
111,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
112,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
112,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
113,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
113,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
113,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
114,1,Headache,Headaches NEC,Headaches,Nerv,N
114,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
114,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
114,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
116,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
116,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
117,1,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
118,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
118,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
118,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
118,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
118,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
118,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
118,9,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
118,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
118,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
119,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
120,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
120,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
121,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
121,2,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
121,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
121,5,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
121,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,7,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
121,8,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
121,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
122,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
122,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
122,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
123,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
123,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
123,3,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
123,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
123,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
124,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
125,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
125,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
126,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
126,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
128,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
129,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
129,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
129,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
129,4,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
129,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
130,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
131,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
132,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
134,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
134,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
134,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
134,4,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
134,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
134,6,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
134,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
134,8,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
135,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
135,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
135,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
135,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
137,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
138,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
139,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
139,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
139,3,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
140,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
140,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
140,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
142,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
142,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
143,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
143,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
144,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
145,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
145,3,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
146,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
146,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
147,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
147,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
148,1,Arteriovenous malformation,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
148,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
148,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
148,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
148,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
148,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
149,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
150,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
150,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
151,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
152,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
152,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
153,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
153,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
154,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
155,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
156,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
156,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
157,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
157,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
158,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
159,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
160,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
161,1,Leukoerythroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
162,1,Antiphospholipid antibodies positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
162,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
162,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
162,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
162,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
162,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
162,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
162,8,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
163,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
163,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
163,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
163,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
163,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
163,6,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
163,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
164,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
165,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
165,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
165,3,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
165,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
166,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
166,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
166,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
166,4,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
167,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
168,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
168,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
169,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
169,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
169,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
169,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
171,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
171,2,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
171,3,Headache,Headaches NEC,Headaches,Nerv,N
172,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
173,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
173,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
174,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
174,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
174,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
175,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
175,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
175,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
176,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
176,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
176,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
176,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
176,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
176,7,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
177,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
177,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
178,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
178,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
179,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
180,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
180,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
181,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
181,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
181,3,Scleral discolouration,"Scleral structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
181,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,5,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
182,1,Headache,Headaches NEC,Headaches,Nerv,N
183,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
184,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
184,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
184,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
184,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
184,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
185,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
185,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
186,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
187,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
188,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
189,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
190,1,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
191,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
192,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
193,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
194,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
194,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
195,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
195,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
196,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
197,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
198,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
199,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
200,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
200,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
200,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
200,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
200,5,Headache,Headaches NEC,Headaches,Nerv,N
200,6,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
200,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
200,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
200,9,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
200,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
201,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
202,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
202,2,Headache,Headaches NEC,Headaches,Nerv,N
202,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
202,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
203,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
203,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
204,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
204,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
205,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
205,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
206,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
206,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
207,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
207,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
207,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
209,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
210,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
212,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
212,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
212,3,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
213,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
213,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
215,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
216,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
216,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
217,1,Platelet count,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
218,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
218,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
219,1,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
220,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,2,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
221,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
222,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
222,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
223,2,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
224,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
224,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
224,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
